Plasminogen activator (PAs) convert the zymogen plasminogen into its proteolytically active form, plasmin (1) . PAs are extremely specific serine proteinases found in a variety of ceils, tissues, and body fluids (2, 3) . They have been classified into two immunologically distinct groups, those that are neutralized by anti-urokinase antibodies (urokinaselike) and those that are neutralized by antitissue activator antibodies (tissue activatorlike) (4) . No cross reactivity has been reported between the two activator groups. Although these molecules activate plasminogen by cleavage of the same arginine-valine bond (5), the mechanism of activation differs considerably. Tissue activator, unlike urokinase, requires a cofactor before its PA activity can be expressed (6) . Interestingly, this cofactor appears to be fibrin itself (7) .
The plasma fibrinolytic system is responsible for the dissolution of blood clots, and thus promotes continued circulation of blood through an unobstructed vascular bed. Unfortunately, the origin and characteristics of the PA in blood responsible for initiating and controlling this process remain unclear (5) . The fibrin-dependency of tissue activators and their fibrinbinding properties guarantee their accumulation and activation on the surface of fibrin clots. These characteristics, together with the recent findings that these molecules are both efficient and specific thrombolytic agents (8) suggest that tissue activator, not urokinase, is the physiologically relevant vascular activator. We have begun to study the PAs produced by cultured endothelial cells since available information suggests that the vascular activator may originate from the endothelium itself (9, 10) . Here we show that bovine aortic endothelial cells (BAEs) produce multiple molecular weight forms of PA; these forms include both urokinaselike and tissue-activator-like molecules.
MATERIALS AND METHODS

Cell Culture
BAEs were isolated from the aortae of freshly killed cows by the method of Booyse et al. (11 ) and cultured as indicated (12) . The cells used for most of these studies had been passaged 5 to 20 times and were positive for Factor VIII antigen. Cloned BAEs were used in some experiments. One clone was isolated in our laboratory from a single cell that grew out of a primary cell preparation from bovine aorta. Four clones were isolated and kindly provided by Drs. C. Gajdusek and S. Schwartz (13) , and the 6th clone was the generous gift of Dr. W. Laug (14) . All cultures were grown to confluency in 60-mm dishes before use (15) .
Preparation and Treatment of Cell Extracts and Conditioned Medium (CM)
To prepare cellular extracts, cultures were washed twice with cold phosphate buffered saline (PBS) (0.14 M NaCI, 0.01 M sodium phosphate, pH 7.2), extracted with 250 #1 of Triton X-100 (0.5% vol/vol in PBS; Sigma Chemical Co., St. Louis, MO) and removed with a rubber policeman. The culture dish was washed once with 750 gl PBS, and the extract and wash were pooled. All samples were used immediately after preparation. Conditioned media was prepared by incubating washed monolayers in serum-free MEM for 24 h. This CM was collected, centrifuged at 1,000 g to remove cellular debris and stored in 0.5% Triton X-100 at -30°C until used.
Inactivation studies with diisopropylfluorophosphate (DFP; Sigma Chemical Co.), were performed with Triton X-100-released cellular PA and with CM (in 0.2 M sodium phosphate, pH 7.2). Samples were treated with 1 mM or l0 mM DFP at 37°C. At 30 rain, I h, and 2 h, 100-/d aliquots were removed and quickly frozen in an ethanol dry ice bath. Samples were fractionated by SDS PAGE and analyzed for PA activity on fibrin-agar gels (fibrin autography). To prepare Triton X-100-released PA, cultures were washed twice with cold PBS, scraped into 1 ml of homogenization buffer (0A M Tris-HCl, pH 7.4, 0.25 M sucrose, 1 mM EDTA) and homogenized until 90--95% of the cells were disrupted. The nuclei were removed by centrifugation at 600 g for 10 rain and then the membrane fraction was isolated by centrifugation for 90 rain at 100,000 g. This microsomal pellet was rasuspended in 0.5 ml of 0.1 M sodium phosphate, pH 7.2, an equal amount of Triton X-100 (wt/wt) was added, and tbe residual particulate matter was removed by centrifugation at 100,000 g for 90 rain. This treatment resulted in the release of 85-95% of the PA activily from the membrane fraction.
PAGE
SDS polyacrylamide slab gels and buffers were prepared as described by Laemmli (16) with resolving gels of 9% acrylamide and stacking gels of 4% acrylamide. Samples were applied to the gels and subjected to electrophoresis at 40 V at room temperature. Molecular weight standards included human transferrin (76,000), human serum albumin (65,000), ovalbumin (43,000), chymotrypsinogen (25,700), and soybean trypsin inhibitor (16, 700) . Portions of the gel containing these standards were removed and stained for 30 min with 1% Coomassie Blue and 50% trichloroacetic acid, and then destained in 10% acetic acid. The remaining portion of the gel was processed for fibrin autograpliy to localize PA activity.
Fibrin Autography
To prepare fibrin agar indicator gels (17) , a 2% solution of agarose (LPG agarose, Miles Laboratories, Elkhardt, IN) in water was boiled, cooled to 47°C and mixed with prewarmed PBS containing plasminogen (19.5 /tg/ml) and thrombin (0.6 U/ml). Fibrinogen (10 mg/ml) in PBS (37°C) was added, the solution was mixed rapidly and poured on a glass plate. Final concentrations were 1% agarose, 5.8 t*g/ml plasminogen, 0.18 U/ml thrombin, and 2 mg/ml fibrinogen. The fibrin-agar gel was used immediately. After electrophorasis, the SDS gels were soaked in 2.5% Tiiton X-100 for 1.5 h to remove the SDS, patted dry with a paper towel, and applied to the surface of the fibrin-agar indicator gel. The indicator gel was allowed to develop at 37°C in a moist chamber, and then photographed. The dark areas of the indicator gel correspond to the lyric zones initiated by the interaction of PA in the SDS gel and plasminogen in the indicator gel. No lyric zones were detected in the indicator gel in the absence of plasminogen.
Activity neutralization studies were performed by incorporating rabbit antiurokinase IgG (20 gg/ml) or rabbit antitissue activator IgG (10 #g/ml) into the fibrin-agar indicator gel mixture. A 9% SDS gel containing various PAs was placed on the antibody containing indicator gel and incubated at 37°C. Control fibrin agar plates containing normal rabbit IgG at the same concentrations were also tested.
632 Tilt JOURNAL OF CELL BIOLOGY • VOLUME 94, 1982
Isoelectric Focusing and Two Dimensional Gel Electrophoresis
Iso~lectric focusing of CM was performed in 5% polyacrylamide slab gels containing 6M urea (ultra pure, Schwartz-Mann, Orangeburg, NY), 0.5% Triton X-100, 10% glycerol, and 5% ampholytes (pH 3.5-10, 8-9.5, 9 11 in a ratio of 5:2:1; LKB Instruments, Inc., Rockville, MD). Conditioned media was dialyzed overnight in 0.5% Triton X-100, 6M urea to remove ions before application. The gels were electrofocused on an LKB multiphor system at 15 W for 3 h using electrode solutions of 1 M NaOH and I M H3PO4. After electrofocusing was completed, one lane was removed from the slab gel, sliced into 0.5-cm slices, and each slice was then soaked in 0.5 ml of 0.5% Triton X-100 for 30 min and the pH determined. The slices were allowed to continue soaking overnight and an aliquot assayed for PA activity on 12:'I-fibrin plates. Focused samples were also analyzed by SDS PAGE (2-dimensional gel electrophoresis). A duplicate lane was removed from the focusing gel and soaked for 60 min. in 0.05 M Tris-HC1 pH 8, containing 10% glycerol, 0.025% bromphenol blue, and I% SDS. It was then placed on top of an SDS gel and subjected to fractionation by SDS PAGE as described above. PA activity was localized by fibrin autography.
Assay of Fibrinolytic Activity
PA activity was assayed on ~2'~i-fibrin coated mulliwell tissue culture dishes (24 wells, 16 mm; Costar Data Packaging, Cambridge, MA) as described (15) . The standard cell-free assay contained in 1 ml: 4/Lg human plasminogen, 0.1% gelatin, 0.1 M Tris-HC1, pH 8.1, and a source of PA. Fibrinolysis was not observed when plasminogen or PA was omitted from the reaction mixture, indicating that hydrolysis of the 12'~I-fibrm resulted from conversion of plasminogen into plasmin by PA.
Immunochemistry
Rabbit antiserum raised against human urokinase was a gift from Collaborative Research, Waltham, MA. To prepare IgG fractions, antiserum or nonimmune serum was combined with an equal volume of 0.15 M sodium chloride, and ammonium sulfate was added slowly to 45% saturation. This solution was stirred for 15 min and centrifuged at 20,000 g for 20 min. The pellet was resuspended in 0.15 M sodium chloride and the ammonium sulfate fractionation repeated two more times. The final precipitate was redissolved and dialyzed extensively against 0.07 M potassium phosphate, pH 7.2, and then chromatographed on a DEAEcellulose column equilibrated in the same buffer. The unbound protein was collected, dialyzed against PBS and concentrated to 2 mg/ml of IgG. The rabbit antihuman tissue activator IgG (2 mg/ml) was isolated by adsorption onto Protein A-Sepharose columns as described (4) and was a generous gift from Dr. D. Collen, University of Leuven, Leuven, Belgium.
Miscellaneous
Protein was determined by the method of Bradford (18) using bovine serum albumin as a standard. Radioactivity measurements of 12Sl were performed in a Micromedic gamma spectrometer (Micromedic Systems, Horsham, PA). Plasminogen was prepared by affinity chromatography on lysine-Sepharose as described (19) . Bovine fibrinogen fraction 1 (CalBiochem-Behring Corp., San Diego, CA) was purified free of plasminogen by ethanol precipitation in the presence of lysine (20) . Human a-thrombin was a generous gift from Dr. Fenton (Albany, NY). Purified human urokinase (W.H.O. Standard) was supplied by Dr. A. Johnson, New York University. Human tissue plasminogen activator was purified from cultured melanoma cells and was a gift from Dr. D. Collen (21) .
RESULTS
Fractionation of Cellular PAs by SDS PAGE
Cell extract and CM were fractionated by SDS PAGE and 5) . In a few preparations, additional forms of PA with molecular weights of 51,000 (extract) and 55,000 (CM) were also detected, although conditions under which they were generated have not been established. No activity was observed in the absence of plasminogen. These complex lysis patterns were not altered when samples were prepared in the presence of soybean trypsin inhibitor (50/~g/ml) and analyzed in the presence of 8 M urea (not shown). However, prolonged incubation of cell extract or CM at 37 °C, or repeated freezing and thawing of the samples generated PAs of Mr 41,000 and 30,000. These forms are probably degradation products of higher molecular weight forms. The molecular weights of the various cell associated and secreted PAs are summarized in Table I . Similar results were obtained when CM and extract from cloned BAEs was analyzed by these techniques (unpublished observation).
fractionation of Cellular P A s by
Isoelectric Focusing
The isoelectric points (pI) of the various forms of PA in CM were determined (Fig. 2) . Dialyzed CM was electrofocused as indicated. The gel was sliced into 5-mm sections and each slice was then tested for fibrinolytic activity on ~25I-fibrm coated dishes. Two areas of activity were observed. The most active material accumulated between pH 8.4-8.6 with the peak at pH 8.5 ( Fig. 2A) . The less active material corresponded to a pI 
Properties of Plasminogen Activators Produced by Bovine Aortic Endothelial Cells
Cell-associated Secreted
Mr Mr pl
48,000 4-2,900 52,000 + 2,200 8.5 74,600 +--2,000 74,000 4-4,600 7.6 80,000-100,000 80,000-100,000 7.6 I00,000 +_ 2,900 I00,000 + 3,300 7.6
Cell extract and CM were fractionated by SDS PAGE and PA activity localized on a fibrin-agar gel. Molecular weights are an average of at least five determinations. The pls are calculated from experiments similar to those shown in Fig. 2 and are the result of two separate determinations.
FIGURE 2 Analysis of cellular PAs by isoelectric focusing. Conditioned media was electrofocused on a 5% acrylamide slab gel as indicated in Materials and Methods. Lanes parallel to the direction of migration were cut out of the gel and treated as follows: (A) The gel strip was cut into 0.5-cm slices, each slice was then incubated in 0.5 ml of 0.5% Triton X-100 for 30 min at which time the pH of the sample was determined (C) O). Incubation was continued for 16 h at 4°C to allow PA to diffuse out of the gel slice. The PA activity of these samples was determined ( H ) .
(B) A duplicate lane from the isoelectric focusing gel was subjected to further fractionation by SDS PAGE. PA activity was localized by fibrin autography. The separate lane at the left shows CM fractionated only by SDS PAGE.
value of 7.4-7.8, with the peak of activity at pH 7.6. To relate these isoelectric forms to the molecular weight forms shown in Fig. 1 , focused samples were subjected to additional fractionation by SDS PAGE (Fig. 2B) . The PA form ofpI 8.5 consisted of a single molecular species of Mr 52,000. Unexpectedly, the smaller peak of activity (pI 7.5) contained all the higher molecular weight forms (Mr 74,000-100,000). The pI of the various molecular weight forms of activator are summarized in Table I .
I m m u n o l o g i c a l Characterization of Cellular PAs
Urokinase and tissue activator were fractionated by SDS PAGE and then analyzed by fibrin autography. The fibrin indicator gels contained either anti-urokinase IgG or antitissue activator lgG. Nonimmune IgG was added to parallel fibrin indicator gels as controls. The presence of antitissue activator IgG blocked the development of tissue activator initiated lytic zones (Fig. 3) but did not affect the activity of purified urokinase. Conversely, the presence of antiurokinase IgG neutralized urokinase activity but was not effective against tissue activator. The activities of the multiple cellular PA forms also showed differential sensitivity to these IgG fractions (Fig. 4) . Anti-urokinase completely neuralized the activity of the Mr 52,000 form in CM (lane 2) but had no effect on the activity of the other forms (Mr 74,000-100,000). In contrast, the presence of antitissue activator IgG (lane 3) blocked the activities of the high molecular weight forms but had little detectable effect on the activity of the lower molecular weight forms. These results were confirmed with CM prepared from cloned BAEs (unpublished observation). Fibrin-agarose plates containing nonimmune IgG did not affect the activity of any of the PA forms.
Sensitivity of Cellular PAs to Inactivation by DFP
The relative sensitivity of the various PA forms to inactivation by DFP was assessed. CM was treated with DFP for U; lanes 1, 3, 5) and tissue activator {0.01 U; lanes 2, 4, 6) were subjected to analysis by SDS PAGE and activity localized on fibrin-agar gels containing 80 ~g/ml of either nonimmune IgG (lanes 1 and 2) , anti-tissue activator IgG (lanes 3 and 4) or anti-urokinase IgG (lanes 5 and 6). The gels were allowed to develop for 6 h. various times, fractionated by SDS PAGE, and residual PA activity was then localized by fibrin autography (Fig. 5) . Although the 74,000 form was almost completely inactivated by treatment with 1 mM DFP (lanes A2 and B2), the 52,000-dalton form remained relatively active even after incubation with 10 mM DFP (lanes A3 and B3) . The 100,000-dalton form was apparently refractory to DFP treatment since no change in the activity of this form was observed after 2 h of exposure to 10 mM DFP (lane B3). Treatment of CM with 40 mM DFP did not decrease the activity of this molecule (not shown). To insure that residual PA activity represented a DFP-insensitive molecule and was not simply due to hydrolysis and inactivation of the DFP during the incubation period, 0.5 U of urokinase was added to the CM sample that previously had been treated with 1 mM DFP for 2 h (the sample shown in lane A 2). The mixture was incubated for an additional 30 min and then analyzed for urokinase activity. The urokinase was completely inactivated by this treatment (lane C2) even though cellular PA activity was still detected at 3,1r 52,000. The DFP sensitivity of cell associated PAs was identical to their corresponding secreted forms (not shown). 
D I S C U S S I O N
A variety of normal and transformed cells in culture have been shown to produce multiple, molecular weight forms of PA (22) (23) (24) (25) . These PAs were found to range in size from Mr 36,000 to Mr 100,000 and larger. The lower molecular weight PAs from several of these cell lines (Mr -50,000) were neutralized by antiurokinase, but the activity of the larger molecular weight forms was apparently resistant to such treatment. Although this resistance suggests that the larger forms may be tissueactivator-like PAs, direct immunochemical and functional evidence for this conclusion is lacking. The relationship of the various forms to each other is not at all clear from these studies. Our studies with cultured endothelial cells resolve many of these uncertainties. Analysis of cell extracts and conditioned media from cultured BAEs by SDS PAGE revealed the presence of at least three distinct molecules with PA activity, and a number of others not clearly resolved by this approach (Fig. 1) . That these activities result from the presence of only two classes of activator can be argued from the following observations. First, the complex molecular weight pattern observed by SDS PAGE reduced to a rather simple, two component pattern upon isoelectric focusing (Fig. 2 A) . Symmetrical peaks of PA activity were detected at pH 8.5 and at pH 7.6. Subsequent fractionation of the focused samples by SDS PAGE (Fig. 2 B) revealed that the activity recovered at pH 8.5 contained only one molecular species of activator, that of Mr 52,000. This form was not detected at the lower isoelectric point. The size and charge properties of the Mr 52,000 form are similar to those reported for urokinase (26) . All of the higher molecular weight forms (Mr 74,000-100,000) migrated to one position in the gel, at pH 7.5. The higher molecular weight, lower pI of these other forms is consistent with the properties of tissue-activator-like PAs (21, 27) . Second, and in agreement with these conclusions, are the antibody neutralization experiments. Only the activity of the Mr 52,000 form was blocked by antiurokinase (Fig. 3) ; it was not affected by antitissue activator (Fig. 4) . The activity of all the high molecular weight forms (Mr 74,000-100,000) was neutralized by antitissue activator (Fig. 4) but was not affected by anti-urokinase (Fig. 3) . Third, the high molecular weight forms behaved as a single class of biochemically similar molecules with respect to their interaction with fibrin (Loskutoff and Mussoni, unpublished observations). All of these forms not only bound to fibrin, but also appeared to require fibrin for their activity. This fibrin cofactor requirement is the primary functional distinction between tissue-type and urinary PAs (6) . The Mr 52,000 form resembled urokinase in that it showed no association with fibrin.
Thus, it is clear from the above considerations that the Mr 52,000 form is a urokinaselike PA, while the Mr 74,000-100,000 forms behave in all respects like tissue-type PAs. Whether these two classes of PA are actually products of two separate genes (22) remains to be determined. Similarly, the exact relationship among the multiple forms of tissue-type PA (Mr 74,000--100,-000) remains unclear. Although it is possible that they are products of multiple genes, the fact that they demonstrate similar pls, are sensitive to the same antisera, and interact similarly with fibrin, suggests a common origin from a single gene. The DFP-inactivation studies (Fig. 5) would seem to suggest a precursor-product relationship. That is, the relative insensitivity to DFP of the Mr 100,000 form is consistent with the behavior of a proenzyme. Like other zymogen activation reactions (28) , activation in this case would be expected to be a proteolytic process resulting in the formation of a lower molecular weight, DFP-sensitive molecule. The Mr 74,000 form has these properties. The relative insensitivity of the unresolved activity between Mr 80,000-100,000 suggests that this material may represent inactive degradation products of the larger form. The ability to detect PA activity at all in DFP-resistant material seems at first glance, to be inconsistent with this model. However, this activity may arise after treatment with DFP, perhaps during SDS PAGE, and may only reflect a small percentage of the potential activity of the molecule. Conclusive support for these speculations awaits purification of the relevant molecules and specific activity determinations.
It is intriguing that cells of the vascular wall should be associated with both tissue-type (fibrin-dependent) and urokinaselike (fibrin-independent) PA activity. It may be that expression of both activities is critical for the role of the endothelium in maintaining vessel patency. On the other hand, recent observations indicate that urokinase is a relatively ineffective thrombolytic agent when compared to tissue-type PAs (8) , suggesting that it may be important for processes other than fibrinolysis (29) . Rijken et al (4) detected only tissuelike PA activity in sections of the vascular wall. This finding differs from the results presented here and may reflect species or tissue specificity, or changes that occur in cultured cells. It is also possible that the presence of both types of activator reflects a heterogeneity of cells in our cultures. If so, it is unlikely that such heterogeneity is due to the presence of a subpopulation of nonendothelial vascular cells (i.e., smooth muscle cells or fibroblasts) since the morphology of cultures maintained at confluency for 2 wk and fed every 3 d, did not change from the "cobblestone" appearance of the original cultures. If the other ceils were present, the cultures would quickly convert to a multilayered population of elongated cells under these conditions (30) . Laug (14) recently observed multiple molecular weight forms of PA in a cloned isolate of BAEs. We also have confirmed our results with six separate clonal isolates, indicating directly that BAEs produce both types of PA. Because BAEs may be phenotypicaUy unstable (31) , it is possible that the cultures consisted of two subpopulations of endothelial cells with one producing only the urokinaselike molecule and the other the tissue-type PAs. Satisfactory resolution of this possibility will depend upon development of techniques to detect both activities in single cells. In any case, it is clear that endothelium has the potential to produce both classes of activator. How expression of each is regulated, and the relative importance of each in in vivo fibrinolysis will await further studies.
